Ken Griffin Applied Therapeutics Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 138,400 shares of APLT stock, worth $59,512. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138,400
Previous 201,300
31.25%
Holding current value
$59,512
Previous $171,000
60.82%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding APLT
# of Institutions
90Shares Held
100MCall Options Held
176KPut Options Held
165K-
Vestal Point Capital, LP New York, NY11.5MShares$4.95 Million0.4% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA11.3MShares$4.85 Million6.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.4MShares$4.46 Million0.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL7.8MShares$3.35 Million2.55% of portfolio
-
Black Rock Inc. New York, NY6.57MShares$2.83 Million0.0% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $20.6M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...